TSS
BMRN icon

Two Sigma Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

Two Sigma Securities’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,200
Closed -$225K – 1788
2024
Q3 		$225K Sell
3,200
-9,700
-75% -$811K ﹤0.01% 2039
2024
Q2 		$1.06M Buy
12,900
+7,700
+148% +$641K 0.01% 1039
2024
Q1 		$454K Buy
5,200
+2,600
+100% +$233K ﹤0.01% 1645
2023
Q4 		$251K Buy
+2,600
New +$230K ﹤0.01% 2169
2021
Q3 		– Sell
-2,700
Closed -$225K – 1568
2021
Q2 		$225K Buy
+2,700
New +$214K 0.01% 1203
2021
Q1 		– Sell
-3,900
Closed -$342K – 918
2020
Q4 		$342K Sell
3,900
-400
-9% -$31.7K 0.01% 930
2020
Q3 		$327K Sell
4,300
-1,200
-22% -$121K 0.01% 806
2020
Q2 		$678K Buy
5,500
+3,100
+129% +$308K 0.02% 514
2020
Q1 		$203K Sell
2,400
-19,600
-89% -$1.69M ﹤0.01% 1060
2019
Q4 		$1.86M Buy
22,000
+17,400
+378% +$1.31M 0.01% 758
2019
Q3 		$310K Sell
4,600
-5,700
-55% -$439K ﹤0.01% 1519
2019
Q2 		$882K Buy
10,300
+3,800
+58% +$325K 0.01% 785
2019
Q1 		$577K Buy
6,500
+3,100
+91% +$287K 0.01% 808
2018
Q4 		$290K Sell
3,400
-10,700
-76% -$1.02M ﹤0.01% 1406
2018
Q3 		$1.37M Sell
14,100
-29,400
-68% -$2.93M 0.01% 895
2018
Q2 		$4.1M Buy
43,500
+12,900
+42% +$1.13M 0.02% 562
2018
Q1 		$2.48M Buy
+30,600
New +$2.63M 0.01% 763

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's BMRN Position: Q1 2026 in Review

Two Sigma Securities opened a new position in BioMarin Pharmaceuticals (BMRN) in Q1 2026: 22,096 shares worth $1.25M. The stake represents 0.15% of the portfolio and ranks #166 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BMRN as recently as Q2 2025.

Two Sigma Securities first reported a position in BMRN in Q2 2017 and has held it in 18 quarters since. The position peaked at $7.27M in Q3 2024. 555 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Two Sigma Securities held 22,096 shares of BioMarin Pharmaceuticals worth $1.25M as of Q1 2026.
  • BioMarin Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
  • BioMarin Pharmaceuticals made up 0.15% of Two Sigma Securities's portfolio in Q1 2026, its #166 holding.
  • Two Sigma Securities first reported a position in BioMarin Pharmaceuticals in Q2 2017 and has held it in 18 quarters since.
  • Two Sigma Securities's BioMarin Pharmaceuticals position peaked at $7.27M in Q3 2024.
  • 555 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.